Fairview Recovery Services
Adult Chemical Dependency Program
2450 Riverside Avenue, Minneapolis, MN 55454
Fairview Recovery Services Adult Chemical Dependency Program is a residential facility in Minneapolis, MN offering substance use treatment. Buprenorphine is used for opioid use disorder. It reports accepting self-payment, Medicaid, and private insurance.
Licenses and accreditations
- State department of healthLicensed by the state's department of health.
- State substance use treatment agencyLicensed by the state's substance use treatment agency.
- The Joint CommissionAccredited by The Joint Commission.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Long-term residential
- Living at the facility for more than 30 days.
- Residential/24-hour residential
- Living at the facility during treatment.
- Short-term residential
- Living at the facility for 30 days or less.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Accepts clients using MAT but prescribed elsewhere
- Accepts clients whose medication for opioid use is prescribed elsewhere.
Payment
- Accepted
- Cash or self-payment; Medicaid; Private health insurance; A state-financed health insurance plan other than Medicaid.
Who they serve
- Ages served
- Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
- Sex
- Female; Male.
- Programs for
- Adult men; Adult women; Clients with co-occurring mental and substance use disorders; Pregnant/postpartum women.
- Languages
- Sign language services for the deaf and hard of hearing.
More details this facility reports
- Hospitals
- General Hospital (including VA hospital).
- External Opioid Medications Source
- In-network prescribing entity; No formal relationship with prescribing entity.
- Type of Alcohol Use Disorder Treatment
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere.
- External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity; No formal relationship with prescribing entity.
- Pharmacotherapies
- Buprenorphine with naloxone; Nicotine replacement.
- Treatment Approaches
- 12-step facilitation; Anger management; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling.
- Facility Operation (e.g., Private, Public)
- Private non-profit organization.
- Assessment/Pre-treatment
- Complete medical history/physical exam; Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Professional interventionist/educational consultant; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
- Testing
- Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; Metabolic syndrome monitoring; STD testing; TB screening; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV).
- Transitional Services
- Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
- Recovery Support Services
- Housing services; Mentoring/peer support; Recovery coach; Self-help groups.
- Education and Counseling Services
- Family counseling; Group counseling; HIV or AIDS education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Hepatitis education, counseling, or support; Individual counseling; Smoking/vaping/tobacco cessation counseling; Substance use disorder education.
- Medical Services
- Hepatitis A (HAV) vaccination; Hepatitis B (HBV) vaccination.
- Facility Smoking Policy
- Smoking permitted in designated area.
- Facility Vaping Policy
- Vaping not permitted.
- Ancillary Services
- Mental health services; Suicide prevention services.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.